ZIAGEN 300 mg, film-coated tablet 60 tablets
Active ingredients: Abacavir sulfate, Abacavir
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored60 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZIAGEN 300 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 60 comprimé(s)
- Marketing authorisation holder
- VIIV HEALTHCARE UK (ROYAUME-UNI)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 13 Dec 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68556562CIP73610897CIP133400936108974Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ABACAVIR BASEcomprimé | 300 mg · un comprimé | FT |
| ABACAVIR (SULFATE D')comprimé | 351 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.